Finance

Beta
Lists
1STMN:BIT
Straumann Holding AG
€103.00
+17.71%
(+15.50) 1D
Jun 3, 5:26:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1STMN...
Open
€103.00
High
€103.00
Low
€103.00
Mkt. cap
14.96B
Avg. vol.
41.00
Volume
632.00
52-wk high
€119.00
52-wk low
€83.50
No. of employees
12K
Open
€103.00
High
€103.00
Low
€103.00
Mkt. cap
14.96B
Avg. vol.
41.00
Volume
632.00
52-wk high
€119.00
52-wk low
€83.50
No. of employees
12K
News stories
From sources across the web
Profile
Straumann Group is a Swiss company based in Basel manufacturing dental implants and specialized in related technologies. The group researches, develops, manufactures and supplies dental implants, instruments, biomaterials, CADCAM prosthetics, digital equipment, software, and clear aligners for applications in replacement, restorative, orthodontic and preventative dentistry. The Straumann Group also offers services to the dental profession worldwide, including training and education, which is provided in collaboration with the International Team for Implantology and the Instituto Latino Americano de Pesquisa e Ensino Odontológico. Its products and services are available in more than 100 countries through a broad network of distribution subsidiaries and partners. Wikipedia
About Straumann Holding AG
CEOGuillaume Daniellot | Guillaume Daniellot
Employees11.6K
Founded1954
HeadquartersBasel, Basel City, Switzerland
SectorMedical device
Website-
Last report
Apr 29, 2026
Fiscal period
Q1 2026
EPS / Est. (CHF)
- / -
Revenue / Est. (CHF)
673.00M / 676.98M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
674.10M
674.10M
628.60M
628.60M
Cost of goods sold
188.11M
188.11M
201.43M
201.43M
Cost of revenue
188.11M
188.11M
201.43M
201.43M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
310.81M
310.81M
280.83M
280.83M
Operating expense
308.41M
308.41M
277.79M
277.79M
Total operating expenses
496.51M
496.51M
479.22M
479.22M
Operating income
177.59M
177.59M
149.38M
149.38M
Other non operating income
-500.00
-500.00
-3.58M
-3.58M
EBT including unusual items
146.25M
146.25M
81.29M
81.29M
EBT excluding unusual items
159.03M
159.03M
136.50M
136.50M
Income tax expense
27.16M
27.16M
21.37M
21.37M
Effective tax rate
18.57%
18.57%
26.29%
26.29%
Other operating expenses
-2.40M
-2.40M
-3.04M
-3.04M
Net income
118.22M
118.22M
59.74M
59.74M
Net profit margin
17.54%
17.54%
9.50%
9.50%
Earnings per share
-
-
-
-
Interest and investment income
42.10M
42.10M
48.95M
48.95M
Interest expense
-56.23M
-56.23M
-38.43M
-38.43M
Net interest expenses
-14.12M
-14.12M
10.52M
10.52M
Depreciation and amortization charges
-
-
-
-
EBITDA
217.12M
217.12M
158.16M
158.16M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more